Brain-computer interfaces are at the forefront of therapeutic technological development. Enabling high-fidelity reception of neural impulses, restored motor and sensory function, improved sleep and enhanced lifestyles, BCI applications are as varied as the patients they were invented to serve. Recently, high-profile BCI entities have attracted mainstream investors to the space.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Costly chronic kidney disease and end-stage renal disease, affecting more than 37 million Americans, are long overdue for a major care overhaul. Now, a sweeping new Advancing American Kidney Health Executive Order—including changes in Medicare provider payment models and a focus on the development of innovative new device technologies—will hopefully be the game-changers that this public health crisis truly needs.Subscribe now to read the full analysis
Medical Alley Innovation Summit, September 11-12th, is next month. Register today to reserve your seat.Register Learn More
'Meet the Innovators' Season 2, Episode 10: A video interview with Andrew Bartynski, co-founder, AesculaTech. Los Angeles-based start-up, AesculaTech, Inc., is developing a platform of temperature-responsive smart materials, including their first product, AesculaGel, a punctal plug for the treatment of dry eye syndrome that is applied as a liquid then solidifies at body temperature and blocks tear ducts.Subscribe now to read the full analysis